Best Pharmaceutical Stocks To Follow Now – July 17th

Abbott Laboratories, Eli Lilly and Company, D-Wave Quantum, Pfizer, and Thermo Fisher Scientific are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that research, develop, manufacture and market medicinal drugs and therapies. Their performance is typically driven by factors such as clinical trial outcomes, regulatory approvals, patent expirations and changes in healthcare policy. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Abbott Laboratories (ABT)

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière’s disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.

Abbott Laboratories stock traded down $10.57 during mid-day trading on Thursday, hitting $121.17. The company had a trading volume of 18,127,983 shares, compared to its average volume of 6,812,451. The company has a current ratio of 1.78, a quick ratio of 1.27 and a debt-to-equity ratio of 0.26. The stock’s 50 day moving average price is $133.43 and its two-hundred day moving average price is $129.32. Abbott Laboratories has a 12 month low of $99.71 and a 12 month high of $141.23. The company has a market capitalization of $210.81 billion, a PE ratio of 15.71, a price-to-earnings-growth ratio of 2.50 and a beta of 0.73.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Eli Lilly and Company stock traded down $28.45 during mid-day trading on Thursday, reaching $761.35. 2,425,990 shares of the stock traded hands, compared to its average volume of 3,793,792. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.37 and a quick ratio of 1.06. The business’s 50-day moving average is $766.12 and its 200-day moving average is $799.91. The stock has a market capitalization of $721.56 billion, a PE ratio of 62.00, a price-to-earnings-growth ratio of 1.12 and a beta of 0.40. Eli Lilly and Company has a 12-month low of $677.09 and a 12-month high of $972.53.

D-Wave Quantum (QBTS)

D-Wave Quantum Inc. develops and delivers quantum computing systems, software, and services worldwide. The company offers Advantage, a fifth-generation quantum computer; Ocean, a suite of open-source python tools; and Leap, a cloud-based service that provides real-time access to a live quantum computer, as well as access to Advantage, hybrid solvers, the Ocean software development kit, live code, demos, learning resources, and a vibrant developer community.

Shares of NYSE QBTS traded up $2.18 during mid-day trading on Thursday, reaching $19.09. The company’s stock had a trading volume of 75,983,482 shares, compared to its average volume of 49,086,193. The firm has a market capitalization of $5.58 billion, a PE ratio of -31.81 and a beta of 1.40. The stock has a fifty day moving average of $15.51 and a two-hundred day moving average of $9.82. The company has a debt-to-equity ratio of 0.15, a current ratio of 20.73 and a quick ratio of 20.61. D-Wave Quantum has a 52 week low of $0.75 and a 52 week high of $19.77.

Pfizer (PFE)

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.

NYSE PFE traded down $0.15 during trading on Thursday, hitting $24.46. 31,804,575 shares of the stock traded hands, compared to its average volume of 41,912,882. The company has a market capitalization of $139.08 billion, a P/E ratio of 17.74, a price-to-earnings-growth ratio of 0.90 and a beta of 0.58. The firm has a 50-day simple moving average of $23.99 and a 200-day simple moving average of $24.77. The company has a quick ratio of 0.96, a current ratio of 1.26 and a debt-to-equity ratio of 0.64. Pfizer has a 12-month low of $20.92 and a 12-month high of $31.54.

Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

Shares of Thermo Fisher Scientific stock traded up $5.80 on Thursday, reaching $422.11. The company had a trading volume of 1,309,089 shares, compared to its average volume of 2,009,964. The firm has a market cap of $159.34 billion, a price-to-earnings ratio of 24.77, a P/E/G ratio of 2.22 and a beta of 0.77. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.77 and a quick ratio of 1.38. The firm’s 50-day moving average price is $409.84 and its two-hundred day moving average price is $474.37. Thermo Fisher Scientific has a 1 year low of $385.46 and a 1 year high of $627.88.